Clinical Trial NCT04747613
Trial
Novartis – CLNP023C12001B
Clinical trial ID
NCT04747613
Drug name
LNP023 Iptacopan
Company:
Novartis
Drug trade name
Fabhalta®
Phase of study
3
Current status
Recruiting
Start
07/2021
Substance
Low molecular compound
Research question
Long-term evaluation
Delivery method of drug
Oral
Frequency
2 x daily
Clinical trial locations
Brazil China Czechia France Germany Italy Japan Lithuania Malaysia Netherlands Singapore South Korea Spain Taiwan UK USA